A Baltimore vaccine developer that takes its name from the Latin phrase for "to advance or improve" will be doing just that to its vaccine innovation center near Tarrytown, NY.

During the process, Profectus BioSciences’ center will roughly triple in size as part of an expansion fueled by its acquisition of technologies from Wyeth and the University of Maryland School of Medicine's Institute of Human Virology, as well as plans to launch six Phase 1 studies into the safety and effectiveness of its HIV prime-boost therapeutic vaccine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.